Literature DB >> 19415579

Soft tissue augmentation with ArteFill.

John M Hilinski1, Steven R Cohen.   

Abstract

ArteFill is a novel, third-generation polymethylmethacrylate (PMMA) injectable filler with unique properties. When compared with predecessor materials, ArteFill demonstrates improved biocompatibility as a result of more uniform PMMA microsphere size and shape. This translates into less adverse events after placement. ArteFill can provide a permanent volume enhancement by stimulation of fibroblasts that encapsulate nonabsorbable microspheres with collagen deposition. Currently, ArteFill is FDA approved for permanent augmentation of moderately deep nasolabial folds. It is also commonly used off-label for augmentation of other skin creases and regional areas of volume deficiency, such as the tear trough-malar and marionette line-prejowl sulcus regions. The key to success with ArteFill is a conservative approach with avoidance of overcorrection. Proper technique includes deep dermal to subcutaneous placement with full correction achieved gradually over several treatments. Complications are mostly limited to nodule formation, which is easily managed in most cases with conservative intervention.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19415579     DOI: 10.1055/s-0029-1220651

Source DB:  PubMed          Journal:  Facial Plast Surg        ISSN: 0736-6825            Impact factor:   1.446


  3 in total

1.  Facial soft tissue augmentation with Artecoll(®): A review of eight years of clinical experience in 153 patients.

Authors:  Philip Solomon; Michael Sklar; Rebecca Zener
Journal:  Can J Plast Surg       Date:  2012

2.  Gluteal Augmentation with Polymethyl Methacrylate: A 10-year Cohort Study.

Authors:  Roberto Chacur; Honório Sampaio Menezes; Nívea Maria Bordin da Silva Chacur; Danuza Dias Alves; Rodrigo Cadore Mafaldo; Leandro Dias Gomes; Gisele Dos Santos Barreto
Journal:  Plast Reconstr Surg Glob Open       Date:  2019-05-31

Review 3.  Dermal fillers in aesthetics: an overview of adverse events and treatment approaches.

Authors:  David Funt; Tatjana Pavicic
Journal:  Clin Cosmet Investig Dermatol       Date:  2013-12-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.